课题基金 / 基金详情

Role of Complement in Commensal Microbiota Actions Regulating Sketal Maturation

Role of Complement in Commensal Microbiota Actions Regulating Sketal Maturation
补体在调节骨骼成熟的共生微生物群作用中的作用
批准号:
10656406
负责人:
Jessica Diann Hathaway-Schrader
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-01 至 2027-06-30

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
摘要
英文摘要
Abstract Commensal microbiota critically regulates osteoimmune processes mediating post-pubertal skeletal development. Our studies have shown that the commensal gut microbiota suppresses osteoblastic bone- forming cells and enhances osteoclastic bone-resorbing cells, which impairs bone mass accrual. However, mechanisms discerning commensal microbiota effects on bone across the lifespan are unclear. The study of osteoimmunology has shown that immune cells in the bone marrow regulate bone modeling/remodeling. Despite knowledge that the commensal gut microbiota directs crosstalk with host immunity, immune mechanistic studies elucidating the commensal gut microbiota immunomodulatory effects on skeletal maturation are unclear. Preliminary findings from the investigator’s postdoctoral research work suggest that commensal microbiota-host interactions stimulate complement signaling to have system catabolic effects in the maturing skeleton in health and disease. Complement signaling protects the host from infection and modulates the immune response, highlighting the role of complement in maintaining a homeostatic relationship with the commensal microbiota. Our preliminary data demonstrated that the commensal microbiota upregulates circulating complement anaphylatoxin C3a, which has also been implicated in inflammatory bowel pathogenesis. Complement receptor C3aR is expressed on both osteoblasts and osteoclasts, implying that C3a may be a critical regulator of commensal microbiota effects on the maturing skeleton in health and disease. Three specific aims will address critical in vivo and in vitro studies utilizing transgenic mice deleting C3aR in both osteoblasts and osteoclasts in health and under dextran sodium sulfate (DSS)-induced colitis. These three aims will investigate the overall hypothesis that the commensal gut microbiota upregulation of C3a regulates C3aR derived skeletal maturation in health and disease throughout the lifespan. Aim 1 will elucidate the role of commensal gut microbiota on C3aR-mediated osteoblastogenesis in skeletal maturation and deterioration under normal and inflammatory bowel conditions. Aim 2 will examine commensal gut microbiota actions on C3aR-osteoclastogenic signaling in the maturing and aging skeleton in health and disease. Aim 3 will determine whether probiotic administration regulates C3a/C3aR signaling during post-pubertal skeletal development. Elucidating the relationship between C3/C3aR signaling, the gut microbiota, and bone will provide opportunities for therapeutic interventions to optimize bone mass accrual in young service members and protect against skeletal deterioration in aging Veterans. This research seeks to define osteoimmunological processes regulating peak bone mass accrual to withstand either age-related and/or disease-related skeletal deterioration. These studies will innovatively use bone cells specific C3aR knockdown models to determine microbiota derived complement signaling effects on skeletal maturation. Notably, this work proposes probiotic interventions during a peak bone mass accrual window to define the role of the commensal microbiota on complement C3a/C3aR on the skeleton throughout the lifespan. Additionally, this proposal will provide solid career development in new areas of expertise and career tools necessary for the applicant's transition to an independent VA investigator. This will be accomplished through proposed coursework, hands-on training, networking, and mentoring experiences provided by the CDA- 2 mechanism.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: